Profiel
Cheri L.
Walker is currently Chief Executive Officer at Zeta Corp, Non-Executive Director at Atomo Diagnostics Ltd. since 2022, and Director at Cell IDx, Inc. Former positions include President, Chief Executive Officer & Director at Rhinostics, Inc. from 2020 to 2023; Vice President at Invitrogen Corp.; Analyst at Deutsche Bank Securities, Inc. from 2003 to 2005; Senior Vice President-Corporate Development and Senior Vice President at Charles River Laboratories International, Inc. and Charles River Laboratories, Inc.; Chief Commercial Officer at SeraCare Life Sciences, Inc.; Operating Executive at SFW Capital Partners LP; Vice President-Mergers & Acquisition at Qiagen, Inc. and QIAGEN Sciences, Inc.; and Vice President at Proteomics, Inc. Education includes undergraduate studies at Swarthmore College and a doctorate from Baylor College of Medicine.
Actieve functies van Cheri Walker
| Bedrijven | Functie | Begin |
|---|---|---|
| ATOMO DIAGNOSTICS LIMITED | Directeur/Bestuurslid | 15-11-2022 |
Cell IDx, Inc.
Cell IDx, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as multiplexed tissue profiling company that provides multiplex staining panels, tissue staining and imaging and analysis services | Directeur/Bestuurslid | - |
Zeta Corp
Zeta Corp BiotechnologyHealth Technology Manufactures IVD antibodies | Algemeen Directeur | - |
Eerdere bekende functies van Cheri Walker
| Bedrijven | Functie | Einde |
|---|---|---|
Rhinostics, Inc.
Rhinostics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops automated nasal swab products | Algemeen Directeur | 01-11-2023 |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 28-07-2005 |
SeraCare Life Sciences, Inc.
SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biological based products to serve the global life sciences industry | Corporate Officer/Principal | - |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services | Corporate Officer/Principal | - |
Proteomics, Inc. | Corporate Officer/Principal | - |
Opleiding van Cheri Walker
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 15 |
|---|---|
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services | Electronic Technology |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing and research services on a contract basis | Commercial Services |
Charles River Laboratories, Inc.
Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research models and laboratory animal support services | Commercial Services |
SeraCare Life Sciences, Inc.
SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biological based products to serve the global life sciences industry | Health Technology |
Swarthmore College
Swarthmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SFW Capital Partners LP
SFW Capital Partners LP Investment ManagersFinance SFW Capital Partners invests in companies located in the United States with a revenue of USD 10 - 100 million and EBITDA of USD 3 - 20 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for MBOs, corporate carve-outs, recapitalizations and buyout, growth transactions with an investment size of USD 25 - 100 million. It acquires minority positions in the companies. | Finance |
Qiagen, Inc.
Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides technologies for separating, purifying and handling nucleic acids | Commercial Services |
QIAGEN Sciences, Inc.
QIAGEN Sciences, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures chemical products | Process Industries |
Proteomics, Inc. | |
Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. Medical SpecialtiesHealth Technology Manufactures and markets blood testing vitro diagnostic medical devices | Health Technology |
Cell IDx, Inc.
Cell IDx, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as multiplexed tissue profiling company that provides multiplex staining panels, tissue staining and imaging and analysis services | Commercial Services |
Rhinostics, Inc.
Rhinostics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops automated nasal swab products | Commercial Services |
Zeta Corp
Zeta Corp BiotechnologyHealth Technology Manufactures IVD antibodies | Health Technology |
















